Rosenblatt Maintains Buy on Calix, Lowers Price Target to $45
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Mike Genovese has maintained a Buy rating on Calix (NYSE:CALX) but has reduced the price target from $57 to $45.
January 30, 2024 | 5:58 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Rosenblatt has maintained a Buy rating on Calix but lowered the price target from $57 to $45, indicating a positive outlook but with tempered expectations.
While the Buy rating suggests continued confidence in Calix's fundamentals and potential growth, the reduction in price target may reflect a reassessment of near-term growth prospects or market conditions. This could lead to a mixed reaction in the short term as investors digest the implications of a lower price target while also considering the analyst's continued endorsement of the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100